LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
BT-20 Celastrol
3.33
uM
LJP6
 3
G08
 72
hr
 1657 846 5505 0.1537 -0.2110
BT-20 CGP60474
3.33
uM
LJP5
 1
F02
 72
hr
 1657 1384 5505 0.2514 -0.0711
BT-20 CGP60474
3.33
uM
LJP5
 2
F02
 72
hr
 1657 1352 5505 0.2456 -0.0795
BT-20 CGP60474
3.33
uM
LJP5
 3
F02
 72
hr
 1657 1290 5505 0.2343 -0.0956
BT-20 CGP60474
3.33
uM
LJP6
 1
G02
 72
hr
 1657 938 5505 0.1704 -0.1871
BT-20 CGP60474
3.33
uM
LJP6
 2
G02
 72
hr
 1657 947 5505 0.1720 -0.1847
BT-20 CGP60474
3.33
uM
LJP6
 3
G02
 72
hr
 1657 908 5505 0.1649 -0.1948
BT-20 CHIR-99021
3.33
uM
LJP6
 1
P14
 72
hr
 1657 5343 5505 0.9705 0.9577
BT-20 CHIR-99021
3.33
uM
LJP6
 2
P14
 72
hr
 1657 5521 5505 1.0028 1.0040
BT-20 CHIR-99021
3.33
uM
LJP6
 3
P14
 72
hr
 1657 5815 5505 1.0562 1.0804
BT-20 CP724714
3.33
uM
LJP5
 1
A08
 72
hr
 1657 4231 5505 0.7685 0.6687
BT-20 CP724714
3.33
uM
LJP5
 2
A08
 72
hr
 1657 4461 5505 0.8103 0.7285
BT-20 CP724714
3.33
uM
LJP5
 3
A08
 72
hr
 1657 4800 5505 0.8718 0.8166
BT-20 CP466722
3.33
uM
LJP5
 1
I08
 72
hr
 1657 5713 5505 1.0377 1.0539
BT-20 CP466722
3.33
uM
LJP5
 2
I08
 72
hr
 1657 5325 5505 0.9672 0.9531
BT-20 CP466722
3.33
uM
LJP5
 3
I08
 72
hr
 1657 5110 5505 0.9281 0.8972
BT-20 Crizotinib
3.33
uM
LJP5
 1
A20
 72
hr
 1657 3587 5505 0.6515 0.5014
BT-20 Crizotinib
3.33
uM
LJP5
 2
A20
 72
hr
 1657 3435 5505 0.6239 0.4619
BT-20 Crizotinib
3.33
uM
LJP5
 3
A20
 72
hr
 1657 3686 5505 0.6695 0.5271
BT-20 Momelotinib
3.33
uM
LJP5
 1
P08
 72
hr
 1657 3465 5505 0.6294 0.4697
BT-20 Momelotinib
3.33
uM
LJP5
 2
P08
 72
hr
 1657 3782 5505 0.6869 0.5521
BT-20 Momelotinib
3.33
uM
LJP5
 3
P08
 72
hr
 1657 3567 5505 0.6479 0.4962
BT-20 Dasatinib
3.33
uM
LJP5
 1
D02
 72
hr
 1657 1264 5505 0.2296 -0.1023
BT-20 Dasatinib
3.33
uM
LJP5
 2
D02
 72
hr
 1657 1438 5505 0.2612 -0.0571
BT-20 Dasatinib
3.33
uM
LJP5
 3
D02
 72
hr
 1657 1295 5505 0.2352 -0.0943